|
ARF6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.05169999773136E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.53529999999957E-05 |
| Normal-vs-Stage2 |
8.43970000000693E-05 |
| Normal-vs-Stage3 |
1.96500000049227E-07 |
| Normal-vs-Stage4 |
2.67019999999896E-07 |
| Stage1-vs-Stage2 |
2.723400E-01 |
| Stage1-vs-Stage3 |
1.746420E-02 |
| Stage1-vs-Stage4 |
4.321700E-02 |
| Stage2-vs-Stage3 |
4.679000E-01 |
| Stage2-vs-Stage4 |
6.130200E-01 |
| Stage3-vs-Stage4 |
7.690000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.93350000454728E-08 |
| Normal-vs-AfricanAmerican |
6.156600E-04 |
| Normal-vs-Asian |
7.809800E-01 |
| Caucasian-vs-AfricanAmerican |
6.465800E-01 |
| Caucasian-vs-Asian |
2.358200E-02 |
| AfricanAmerican-vs-Asian |
7.684300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.92670001964279E-09 |
| Normal-vs-Female |
6.40969999999852E-05 |
| Male-vs-Female |
2.793900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.437600E-03 |
| Normal-vs-Age(41-60Yrs) |
6.89059999947617E-07 |
| Normal-vs-Age(61-80Yrs) |
1.08970000023412E-07 |
| Normal-vs-Age(81-100Yrs) |
1.719600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.870200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.463600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.728800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.654800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.494800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.670200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.238800E-01 |
| Normal-vs-Grade 2 |
6.550800E-04 |
| Normal-vs-Grade 3 |
2.64720467768598E-11 |
| Normal-vs-Grade 4 |
1.12219999959251E-07 |
| Grade 1-vs-Grade 2 |
3.817200E-01 |
| Grade 1-vs-Grade 3 |
3.346200E-02 |
| Grade 1-vs-Grade 4 |
5.122300E-02 |
| Grade 2-vs-Grade 3 |
8.634000E-04 |
| Grade 2-vs-Grade 4 |
1.251940E-02 |
| Grade 3-vs-Grade 4 |
7.105600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.00689999996229E-06 |
| Normal-vs-ccB subtype |
4.43589999998828E-06 |
| ccA subtype-vs-ccB subtype |
3.833000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.9398000001013E-07 |
| Normal-vs-N1 |
2.523100E-03 |
| N0-vs-N1 |
6.111800E-01 |
|
|
